Nadeen Abdallah, Christopher Giuliano, Caitlin E Rukat, Brian J Barnes
{"title":"Is There an Association Between Nighttime Correction Scale Insulin and Morning Hypoglycemia in Hospitalized Patients?","authors":"Nadeen Abdallah, Christopher Giuliano, Caitlin E Rukat, Brian J Barnes","doi":"10.1177/00185787251352168","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Correction scale insulin therapy is commonly used in hospitals. There is limited data evaluating the relationship between correction scale administration timing and morning hypoglycemic episodes. <b>Objective:</b> To evaluate the association between morning hypoglycemic episodes in patients who receive their correction scale insulin before meals (AC) or before meals and at bedtime (ACHS). <b>Methods:</b> This is a single-center, retrospective, cohort study of hospitalized patients with a history of diabetes receiving at least 1 long-acting insulin agent. The primary endpoint was the occurrence of hypoglycemia that occurred in the morning. Secondary endpoints included hyperglycemia, hypoglycemia at any time, glycemic variability (quantified as coefficient of variation, CV), and mortality. Since subjects were not randomly assigned to the exposure, inverse probability of treatment weighting (IPTW) was used to balance factors between the study groups. Multivariable analysis for hypoglycemia was conducted using logistic regression weighted by stabilized IPTW. <b>Results:</b> A total of 614 subjects were included in the study with 556 subjects in the ACHS group and 58 subjects in the AC group. Significant differences in the frequency of morning hypoglycemia were not observed between the ACHS and AC groups (30.6% vs 32.8%, respectively) and this finding persisted after IPTW (OR 0.89, 95% CI 0.63-1.25). Secondary outcomes (after IPTW) showed less morning hyperglycemia (OR 0.39, 95% CI 0.26-0.60) and hyperglycemia at any time (OR 0.2, 95% CI 0.11-0.38) in the ACHS group. No difference was observed in hypoglycemia at any time (OR 0.8, 0.57-1.12), glycemic variability (<i>P</i> = .99), and mortality was infrequent (0.5% vs 0%). <b>Conclusion:</b> We did not observe an association between ACHS correction scale and morning hypoglycemia. Hyperglycemia was less frequent in the ACHS group. Our results support the continued use of ACHS correction scale insulin.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"00185787251352168"},"PeriodicalIF":0.7000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12222095/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787251352168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Correction scale insulin therapy is commonly used in hospitals. There is limited data evaluating the relationship between correction scale administration timing and morning hypoglycemic episodes. Objective: To evaluate the association between morning hypoglycemic episodes in patients who receive their correction scale insulin before meals (AC) or before meals and at bedtime (ACHS). Methods: This is a single-center, retrospective, cohort study of hospitalized patients with a history of diabetes receiving at least 1 long-acting insulin agent. The primary endpoint was the occurrence of hypoglycemia that occurred in the morning. Secondary endpoints included hyperglycemia, hypoglycemia at any time, glycemic variability (quantified as coefficient of variation, CV), and mortality. Since subjects were not randomly assigned to the exposure, inverse probability of treatment weighting (IPTW) was used to balance factors between the study groups. Multivariable analysis for hypoglycemia was conducted using logistic regression weighted by stabilized IPTW. Results: A total of 614 subjects were included in the study with 556 subjects in the ACHS group and 58 subjects in the AC group. Significant differences in the frequency of morning hypoglycemia were not observed between the ACHS and AC groups (30.6% vs 32.8%, respectively) and this finding persisted after IPTW (OR 0.89, 95% CI 0.63-1.25). Secondary outcomes (after IPTW) showed less morning hyperglycemia (OR 0.39, 95% CI 0.26-0.60) and hyperglycemia at any time (OR 0.2, 95% CI 0.11-0.38) in the ACHS group. No difference was observed in hypoglycemia at any time (OR 0.8, 0.57-1.12), glycemic variability (P = .99), and mortality was infrequent (0.5% vs 0%). Conclusion: We did not observe an association between ACHS correction scale and morning hypoglycemia. Hyperglycemia was less frequent in the ACHS group. Our results support the continued use of ACHS correction scale insulin.
背景:校正刻度胰岛素治疗是医院常用的一种胰岛素治疗方法。评估校正量表给药时间与早晨低血糖发作之间关系的资料有限。目的:评价接受餐前胰岛素(AC)或餐前睡前胰岛素(ACHS)校正量表的患者早晨低血糖发作的相关性。方法:这是一项单中心、回顾性、队列研究,研究对象为接受至少1种长效胰岛素治疗的糖尿病住院患者。主要终点是发生在早晨的低血糖。次要终点包括任何时间的高血糖、低血糖、血糖变异性(量化为变异系数CV)和死亡率。由于受试者不是随机分配到暴露,因此使用治疗加权逆概率(IPTW)来平衡研究组之间的因素。采用稳定IPTW加权logistic回归对低血糖进行多变量分析。结果:共纳入614例受试者,其中ACHS组556例,AC组58例。ACHS组和AC组在晨间低血糖发生率上没有显著差异(分别为30.6%和32.8%),IPTW后这一发现仍然存在(OR 0.89, 95% CI 0.63-1.25)。次要结局(IPTW后)显示,ACHS组早晨高血糖(OR 0.39, 95% CI 0.26-0.60)和任何时间高血糖(OR 0.2, 95% CI 0.11-0.38)较少。在任何时候的低血糖(OR 0.8, 0.57-1.12)、血糖变异性(P = 0.99)和死亡率均无差异(0.5% vs 0%)。结论:我们没有观察到ACHS校正量表与早晨低血糖之间的关联。ACHS组高血糖发生率较低。我们的结果支持继续使用ACHS胰岛素校正量表。
期刊介绍:
Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.